{"nct_id":"NCT01775124","title":"Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)","status":"COMPLETED","status_verified_date":"2019-08","start_date":"2013-02-22","start_date_type":"ACTUAL","primary_completion_date":"2015-11-23","primary_completion_date_type":"ACTUAL","completion_date":"2015-11-23","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}